Point of Care STI Testing
- Conditions
- Point of Care STI Testing
- Registration Number
- NCT06844045
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Brief Summary
The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 5150
- Patients age 16-24 years receiving POCT or lab-based GC/CT testing
- Patients with known HIV or active PrEP prescriptions.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Rates of HIV Test Completion Day 1 - Measured on date of STI testing Rates of HIV test completion on the day of gonorrhea/chlamydia testing will be compared between those who receive point-of-care vs. lab-based STI testing.
- Secondary Outcome Measures
Name Time Method Number of participants who received PrEP counseling Day 1 - Same day as STI testing encounter PrEP counseling will be measured using visit note data from the date of the STI testing encounter
Time to STI treatment Time from STI diagnosis to treatment, up to 9 months Days between STI test order and delivery of antibiotics for STI treatment, measured using EHR data
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Children's Hospital of Philadelphia
🇺🇸Philadelphia, Pennsylvania, United States